Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 41, Issue 4


Pharmacogenetics and Responders to a Therapy: Theoretical Background and Practical Problems

Jean-Pierre Boissel / François Gueyffier / Michel Cucherat / Giampiero Bricca
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.086


In a narrow meaning, responders to a therapy are all those who will react as expected following the administration of this therapy. However, a wider definition is worth considering: all those for whom the administration of the therapy will be beneficial. Innovative therapies are increasingly expensive and hazardous, and limiting prescriptions to responders is both economically and ethically compulsory. The theoretical basis for such an approach exists. The process of defining the profile of responders consists of identifying the characteristics of the patients that interact with the size of the effect and integrating them quantitatively in a predictive model. The effect model, which is the relation between the risks of the event with and without the treatment, can be used for the prediction. It can integrate interactions of the efficacy with risk factors and/or genes. The data to be used to achieve both the identification of the interactions and the building of the predictive model are those from the studied population, the set of patients enrolled in clinical trials. Hence, the process of defining the therapy is an extrapolation from the studied population. To carry out the extrapolation process one can use various available techniques, of which none fully fits the purpose. No method is currently both fully adequate and validated. Finally, the predictive models, which we need to identify responders, do not exist in practice. Fortunately, new research approaches have been developed recently.

About the article

Published Online: 2005-06-01

Published in Print: 2003-04-25

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 41, Issue 4, Pages 564–572, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.086.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Jean-Pierre Boissel, Michel Cucherat, Patrice Nony, Sylvie Chabaud, François Gueyffier, James M. Wright, Michel Lièvre, and Alain Leizorovicz
Journal of Clinical Epidemiology, 2008, Volume 61, Number 3, Page 301
Giuseppe Lippi, Massimo Franchini, and Emmanuel J. Favaloro
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 5
B. Ribba, P. Tracqui, J.-L. Boix, J.-P. Boissel, and S. R. Thomas
Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2006, Volume 364, Number 1843, Page 1517
J.-P. Boissel
Journal of Internal Medicine, 2004, Volume 255, Number 4, Page 427

Comments (0)

Please log in or register to comment.
Log in